Targeted Therapy in Pediatric AML: An Evolving Landscape
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology and Child Health
Link
https://link.springer.com/content/pdf/10.1007/s40272-021-00467-x.pdf
Reference158 articles.
1. Rasche M, Zimmermann M, Borschel L, Bourquin JP, Dworzak M, Klingebiel T, et al. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia. 2018;32(10):2167–77. https://doi.org/10.1038/s41375-018-0071-7.
2. de Rooij JD, Zwaan CM, van den Heuvel-Eibrink M. Pediatric AML: from biology to clinical management. J Clin Med. 2015;4(1):127–49. https://doi.org/10.3390/jcm4010127.
3. Lalonde E, Wertheim G, Li MM. Clinical impact of genomic information in pediatric leukemia. Front Pediatr. 2017;5:263. https://doi.org/10.3389/fped.2017.00263.
4. Lonetti A, Pession A, Masetti R. Targeted therapies for pediatric AML: gaps and perspective. Front Pediatr. 2019;7:463. https://doi.org/10.3389/fped.2019.00463.
5. Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol. 2000;18(18):3273–9. https://doi.org/10.1200/jco.2000.18.18.3273.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML;Leukemia;2024-05-09
2. Treatment Outcomes of Adolescents Compared to Younger Pediatric Patients with Acute Myeloid Leukemia: Do They Need a Special Approach?;Cancers;2024-03-14
3. The role of flow cytometry in the classification of myeloid disorders;Die Pathologie;2023-11-22
4. AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML;2023-09-23
5. Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia;Journal of Cancer Research and Clinical Oncology;2023-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3